This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Tyme Technologies Dirección
Dirección controles de criterios 3/4
Información clave
Richie Cunningham
Chief Executive Officer (CEO)
US$1.3m
Compensación total
| Porcentaje del salario del CEO | 42.0% |
| Permanencia del CEO | 1.8yrs |
| Participación del CEO | n/a |
| Permanencia media de la dirección | 2.7yrs |
| Promedio de permanencia en la Junta Directiva | 6.1yrs |
Actualizaciones recientes de la dirección
Recent updates
Syros, Tyme Technologies jump more than 20% after hours as shareholders approve merger
Sep 15We Think Tyme Technologies (NASDAQ:TYME) Can Afford To Drive Business Growth
Aug 05
TYME stock surges on merger agreement and Syros Pharmaceuticals
Jul 05Tyme Technologies: Net-Net Biopharma Exploring Strategic Alternatives
May 26We Think Tyme Technologies (NASDAQ:TYME) Can Afford To Drive Business Growth
Mar 19Tyme Technologies Offers Incredible Risk-Reward
Dec 07Here's Why We're Not Too Worried About Tyme Technologies' (NASDAQ:TYME) Cash Burn Situation
Nov 19Tyme Technologies: The Market Missed The Bullish Memo
Aug 27We're Not Very Worried About Tyme Technologies' (NASDAQ:TYME) Cash Burn Rate
Jul 19Tyme Technologies reports FY results
Jun 10Tyme Technologies: Recent Sell-Off Provides Opportunity To Buy At A Discount
May 29Here's Why We're Watching Tyme Technologies' (NASDAQ:TYME) Cash Burn Situation
Mar 26Have Tyme Technologies, Inc. (NASDAQ:TYME) Insiders Been Selling Their Stock?
Feb 19
Tyme falls after equity offer as quarterly data indicate liquidity pressure
Feb 04Tyme stock granted U.S. patent claims for using TYME-19 to treat COVID-19 infections
Feb 03Do Institutions Own Tyme Technologies, Inc. (NASDAQ:TYME) Shares?
Feb 02Revisiting Tyme Technologies
Dec 17Have Insiders Sold Tyme Technologies, Inc. (NASDAQ:TYME) Shares Recently?
Dec 16Is Tyme Technologies (NASDAQ:TYME) In A Good Position To Invest In Growth?
Dec 09Tyme Technologies names new finance chief
Nov 30Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | -US$24m |
| Mar 31 2022 | US$1m | US$564k | -US$24m |
| Dec 31 2021 | n/a | n/a | -US$24m |
| Sep 30 2021 | n/a | n/a | -US$25m |
| Jun 30 2021 | n/a | n/a | -US$26m |
| Mar 31 2021 | US$2m | US$194k | -US$29m |
Compensación vs. Mercado: Richie's total compensation ($USD1.34M) is above average for companies of similar size in the US market ($USD765.87K).
Compensación vs. Ingresos: Richie's compensation has been consistent with company performance over the past year.
CEO
Richie Cunningham (51 yo)
1.8yrs
Permanencia
US$1,344,080
Compensación
Mr. Richard Cunningham, also known as Richie, serves as Chief Executive Officer and Director at Tyme Technologies, Inc. since November 23, 2020. Mr. Cunningham had been the Chief Executive Officer and Pres...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 1.8yrs | US$1.34m | sin datos | |
| Co-Founder & Director | 9.2yrs | US$2.60m | 11.63% $ 6.2m | |
| Chief Financial Officer | 1.3yrs | US$1.29m | 0.0058% $ 3.1k | |
| Chief Legal Officer & Secretary | 4yrs | US$1.19m | 0.061% $ 32.7k | |
| Chief Business Officer | 3.5yrs | US$858.79k | sin datos | |
| Acting Chief Medical Officer | 1.4yrs | sin datos | 0.0057% $ 3.1k |
2.7yrs
Permanencia media
58yo
Promedio de edad
Equipo directivo experimentado: TYME's management team is considered experienced (2.7 years average tenure).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 1.8yrs | US$1.34m | sin datos | |
| Co-Founder & Director | 7.5yrs | US$2.60m | 11.63% $ 6.2m | |
| Independent Director | 7.5yrs | US$138.73k | 0.0034% $ 1.8k | |
| Independent Director | 4.3yrs | US$146.99k | sin datos | |
| Independent Chairman | 3.9yrs | US$166.34k | 0.064% $ 34.2k | |
| Independent Director | 5.5yrs | US$148.24k | 0.058% $ 31.1k | |
| Independent Director & Member of Medical Advisory Board | 7.5yrs | US$122.87k | 0.0034% $ 1.8k | |
| Member of Medical Advisory Board | 6.7yrs | sin datos | sin datos | |
| Member of Medical Advisory Board | no data | sin datos | sin datos | |
| Member of Medical Advisory Board | no data | sin datos | sin datos | |
| Member of Medical Advisory Board | no data | sin datos | sin datos | |
| Member of Medical Advisory Board | no data | sin datos | sin datos |
6.1yrs
Permanencia media
65yo
Promedio de edad
Junta con experiencia: TYME's board of directors are considered experienced (6.1 years average tenure).